{{Rsnum
|rsid=12630592
|Gene=GSK3B
|Chromosome=3
|position=120049399
|Orientation=plus
|GMAF=0.4582
|Gene_s=GSK3B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 44.2 | 46.0 | 9.7
| HCB | 21.9 | 54.0 | 24.1
| JPT | 22.1 | 46.0 | 31.9
| YRI | 0.0 | 4.1 | 95.9
| ASW | 1.8 | 29.8 | 68.4
| CHB | 21.9 | 54.0 | 24.1
| CHD | 17.4 | 51.4 | 31.2
| GIH | 26.7 | 45.5 | 27.7
| LWK | 0.0 | 12.1 | 87.9
| MEX | 39.7 | 51.7 | 8.6
| MKK | 5.1 | 39.1 | 55.8
| TSI | 33.3 | 54.9 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23598903
|Title=Association of GSK-3β Genetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
}}

{{PMID Auto
|PMID=18676680
|Title=Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.
|OA=1
}}

{{PMID Auto
|PMID=19581563
|Title=Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}